<DOC>
	<DOCNO>NCT00353782</DOCNO>
	<brief_summary>This study evaluate people dyslipidemias - disorder affect fat content blood . Fats , lipid , cholesterol triglyceride , carry blood particle call lipoprotein . These particle involve cause blood vessel diseases lead condition like atherosclerosis ( harden artery ) heart attack . Participants undergo accept medical test procedure evaluate condition . Most test result helpful make diagnosis guide treatment . People lipid disorder eligible study . Representative type patient include : - Plasma cholesterol level great 200 mg/dl less 120 mg/dl - Plasma LDL-C level great 130 mg/dl less 70 mg/dl - Plasma HDL-C level great 70 mg/dl less 25 mg/dl - Unusual cholesterol deposit xanthoma ( nodule lipid deposit skin ) Children 2 year age exclude study . Participants undergo follow procedure : - Plasma evaluation . Apolipoproteins ( plasma protein involve metabolism cholesterol , triglyceride , phospholipid , protein blood ) enzymes involved lipid metabolism measure . - Fat biopsy . A small sample fat tissue collect examination . For test , area buttock abdominal wall numbed . A needle inserted fat , small amount tissue suck syringe . - Leukapheresis . White blood cell collect help diagnose lipid disorder . For test , blood collect needle arm vein , similar donate blood . The blood circulates machine separate component , white cell remove . The rest blood return body , either needle another needle arm . - Skin biopsy . Skin cell collect study . The cell grown laboratory amount cholesterol enter leave cell measure , provide information abnormality cholesterol transport . For test , area skin numb anesthetic small circular area remove , use skin punch instrument similar sharp cookie cutter . - Heparin infusion study . Heparin , blood thinner , release enzymes break fat blood . Lipase activity ( breakdown fat ) blood measure follow injection heparin vein .</brief_summary>
	<brief_title>Causes Natural History Dyslipidemias</brief_title>
	<detailed_description>The lipoprotein transport system vital delivery hydrophobic fat carry aqueous environment blood . The lipoprotein particles comprise system polydisperse contain triglyceride , free esterify cholesterol , phospholipids protein . Inborn error lipoprotein transport system lead alteration steady state concentration various lipoprotein metabolism particle . These inborn error lead hyperlipoproteinemia hypolipoproteinemia . Profound change ambient lipoprotein concentration variety clinical manifestation . The present study protocol design permit full evaluation lipid , lipoproteins apolipoproteins , patient potential genetic defect process . We use variety diagnostic procedure assay represent standard care tertiary referral hospital standardize CLIA-Certified , case , require isolation tissue blood cell sample . These specialized assay necessary correctly diagnose treat patient present unusual disorder lipid metabolism ; patient diagnosed standard , CLIA-Certified assay may require tissue blood cell diagnosis adequate treatment . The study population include patient refer Molecular Disease Branch private care provider , academic institution NHLBI-MDB website , follow potential lipid abnormality clinical stigma associate dyslipoproteinemias : ) increase plasma level cholesterol , triglyceride , HDL-cholesterol LDL-cholesterol ; b ) decrease plasma concentration cholesterol HDL-cholesterol ; c ) postprandial hyperlipidemia ) eruptive xanthoma , xanthelasma , tuberous tendinous xanthoma , corneal opacity .</detailed_description>
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>INCLUSION CRITERIA : The follow representative list type patient presentation potential diagnosis eligible protocol : 1 . Plasma cholesterol level great 200 mg/dl less 120 mg/dl include patient diagnose familial hypercholesterolemia , familial combine hyperlipidemia , sitosterolemia , lipoprotein lipase , hepatic lipase apoCII deficiency , dysbetalipoproteinemia . &lt; TAB &gt; 2 . Plasma LDLC level great 130 mg/dl less 70 mg/dl include patient diagnose familial hypercholesterolemia , familial combine hyperlipidemia , lipoprotein lipase , hepatic lipase apoCII deficiency , sitosterolemia , dysbetalipoproteinemia , abetalipoproteinemia hypobetalipoproteinemia . &lt; TAB &gt; 3 . Plasma HDLC level great 70 mg/dl less 25 mg/dl include patient deficiency cholesteryl ester transfer protein , lecithin cholesterol acyltransferase , phospholipid transfer protein , lipoprotein lipase , hepatic lipase , apoCII , Tangier disease . &lt; TAB &gt; 4 . Plasma triglyceride level great 150 mg/dl include patient deficiency lipoprotein lipase , hepatic lipase apoCII , dysbetalipoproteinemia , Type IV Type V hyperlipidemia . EXCLUSION CRITERIA 1 . Inability provide inform consent . In order cognitively impaired individual participate protocol , consent obtain patient 's legal guardian . Participating protocol benefit population patient since facilitate accurate diagnosis treatment dyslipidemia . Since procedure assay list protocol experimental nature , represent standard care tertiary referral hospital , protection need place . 2 . Prisoners institutionalized person allow participate possible need prolong stay Clinical Center . 3 . Children le 2 year age .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 27, 2017</verification_date>
	<keyword>Dyslipidemia</keyword>
	<keyword>Hypertriglyceridemia</keyword>
	<keyword>Hyperalphalipoproteinemia</keyword>
	<keyword>Atheroembolism</keyword>
	<keyword>Atherosclerosis</keyword>
	<keyword>Dyslipoproteinemia</keyword>
	<keyword>Hypercholesterolemia</keyword>
	<keyword>hypoalphalipoproteinemia</keyword>
</DOC>